eGenesis Company
Xenotransplant
Investors
Industry:
Risk Mitigation
Estimated Revenue:
$10M to $50M
Headquarters:
USA
Total Funding:
$265.00
Last Funding Date:
2021
Last Funding Type:
Series C
Investor Type:
Late Stage Venture
Employee Number:
11-50
Investors Number:
27
Founded Date:
2014